Moxifloxacin hydrochloride 60076 is an inhibitor of cathepsin

is an inhibitor of cathepsin K with potential anti-osteoporotic activity

is an orally bioavailable multitargeted receptor tyrosine kinase (RTK) inhibitor with potential antiangiogenic and antineoplastic activities

1094042-01-9

Scangarella-Oman NE

Moxifloxacin hydrochloride 60076 is an inhibitor of cathepsinMoxifloxacin is a fourth generation synthetic fluoroquinolone antibacterial agent. Its antibacterial spectrum includes enteric Gram () rods (Escherichia coli, Proteus species, Klebsiella species), Haemophilus influenzae, atypical bacteria (Mycoplasma, Chlamydia, Legionella), and Streptococcus pneumoniae, and anaerobic bacteria. It differs from earlier antibacterials of the fluoroquinolone class such as levofloxacin and ciprofloxacin in having greater